GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Dividend Yield %

Firebrick Pharma (ASX:FRE) Dividend Yield % : 0.00% (As of May. 17, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Dividend Yield %?

As of today (2024-05-17), the Trailing Annual Dividend Yield of Firebrick Pharma is 0.00%.

The historical rank and industry rank for Firebrick Pharma's Dividend Yield % or its related term are showing as below:

ASX:FRE's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.67
* Ranked among companies with meaningful Dividend Yield % only.

Firebrick Pharma's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

As of today (2024-05-17), the Forward Dividend Yield % of Firebrick Pharma is 0.00%.

Firebrick Pharma's Dividends per Share for the six months ended in Dec. 2023 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Firebrick Pharma Dividend Yield % Historical Data

The historical data trend for Firebrick Pharma's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Dividend Yield % Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23
Dividend Yield %
- - -

Firebrick Pharma Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Dividend Yield % - - - -

Competitive Comparison of Firebrick Pharma's Dividend Yield %

For the Drug Manufacturers - General subindustry, Firebrick Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Firebrick Pharma's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Firebrick Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Firebrick Pharma's Dividend Yield % falls into.



Firebrick Pharma Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Firebrick Pharma  (ASX:FRE) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Firebrick Pharma Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Firebrick Pharma (ASX:FRE) Business Description

Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines